Skip to content

Author

Xianbin Zhang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Targeting ELF3 with Biomimetic Nanotherapy Sensitizes PDAC to Gemcitabine via GSDME-mediated Pyroptosis.

Pancreatic ductal adenocarcinoma (PDAC) continues to be a lethal malignancy with limited effective treatment strategies due to modest intrinsic response to systemic chemotherapy. Moreover, the dense, fibrotic stroma and poor vasculature of pancreatic tumors severely restrict drug penetration and therapeutic efficacy. T...

Zoya Iqbal, Xin Zhang, Yi-Kai Chen et al. · 0 citations
Open access Aug 2026

ELF3 (E74 like ETS transcription factor 3) promotes tumor growth and autophagy in pancreatic cancer

It is observed that high expression of ELF3 leads to a poor overall survival in pancreatic cancer patients and SRT2183, an ELF3-targeting compound that suppresses autophagic flux and tumor growth, represents a promising candidate for further therapeutic development.

Yu-Ru Shang, Ping-Ping Zhang, Yan-Hui Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.